Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy

Transplant International

Volumn 25, Issue 6, 2012, Pages 687-695

  Chung, Byung Ha ^a   Hong, Yu Ah ^a   Kim, Hyun Gyung ^a   Sun, In O ^a   Choi, Sun Ryoung ^a   Park, Hoon Suk ^a   Lee, Sung Hak ^a   Choi, Bum Soon ^a   Park, Cheol Whee ^a   Choi, Yeong Jin ^a   Kim, Yong Soo ^a   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

BK virus; kidney transplantation; nephropathy; real time PCR

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ADULT; BK VIRUS; BK VIRUS ASSOCIATED NEPHROPATHY; BK VIRUS INFECTION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; CYTOLOGY; DELAYED GRAFT FUNCTION; DIAGNOSTIC VALUE; DRUG COST; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; URINALYSIS; VIRUS REPLICATION;

ADULT; BK VIRUS; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIREMIA;

EID: 84861196051     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01480.x     Document Type: Conference Paper

References (38)

1. Hirsch HH,. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant 2002; 2: 25.
2. Costa C, Bergallo M, Astegiano S, et al. Monitoring of BK virus replication in the first year following renal transplantation. Nephrol Dial Transplant 2008; 23: 3333.
3. Nickeleit V, Singh HK, Mihatsch MJ,. Polyomavirus nephropathy: morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens 2003; 12: 599.
4. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
5. Hurault de Ligny B, Etienne I, Francois A, et al. Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients. Transplant Proc. 2000; 32: 2760.
6. Kang YN, Han SM, Park KK, Jeon DS, Kim HC,. BK virus infection in renal allograft recipients. Transplant Proc. 2003; 35: 275.
7. Ahuja M, Cohen EP, Dayer AM, et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 2001; 71: 896.
8. Barri YM, Ahmad I, Ketel BL, et al. Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy. Clin Transplant 2001; 15: 240.
9. Mengel M, Marwedel M, Radermacher J, et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18: 1190.
10. Kiberd BA,. Screening to prevent polyoma virus nephropathy: a medical decision analysis. Am J Transplant 2005; 5: 2410.
11. Purighalla R, Shapiro R, McCauley J, Randhawa P,. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995; 26: 671.
12. Randhawa P, Brennan DC,. BK virus infection in transplant recipients: an overview and update. Am J Transplant 2006; 6: 2000.
13. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
14. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488.
15. Bechert CJ, Schnadig VJ, Payne DA, Dong J,. Monitoring of BK viral load in renal allograft recipients by real-time PCR assays. Am J Clin Pathol 2010; 133: 242.
16. Wiseman AC,. Polyomavirus nephropathy: a current perspective and clinical considerations. Am J Kidney Dis 2009; 54: 131.
17. Randhawa P, Vats A, Shapiro R,. Monitoring for polyomavirus BK And JC in urine: comparison of quantitative polymerase chain reaction with urine cytology. Transplantation 2005; 79: 984.
18. Hirsch HH, Mohaupt M, Klimkait T,. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184: 1494.
19. Hoffman NG, Cook L, Atienza EE, Limaye AP, Jerome KR,. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol 2008; 46: 2671.
20. Limaye AP, Jerome KR, Kuhr CS, et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis 2001; 183: 1669.
21. Viscount HB, Eid AJ, Espy MJ, et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 2007; 84: 340.
22. Randhawa P, Ho A, Shapiro R, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004; 42: 1176.
23. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant 2004; 4: 2082.
24. Laskin BL, Goebel J,. Cost-efficient screening for BK virus in pediatric kidney transplantation: a single-center experience and review of the literature. Pediatr Transplant 2010; 14: 589.
25. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665.
26. Babel N, Fendt J, Karaivanov S, et al. Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples. Transplantation 2009; 88: 89.
27. Almeras C, Foulongne V, Garrigue V, et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation 2008; 85: 1099.
28. Almeras C, Vetromile F, Garrigue V, Szwarc I, Foulongne V, Mourad G,. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients. Transpl Infect Dis. 2011; 13: 101.
29. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation 2006; 81: 117.
30. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus- associated nephropathy. Am J Transplant 2010; 10: 2615.
31. Funk GA, Gosert R, Comoli P, Ginevri F, Hirsch HH,. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 2008; 8: 2368.
32. Koleilat I, Kushnir L, Gallichio M, Conti DJ,. Initiation of a screening protocol for polyoma virus results in a decreased rate of opportunistic non-BK viral disease after renal transplantation. Transpl Infect Dis. 2011; 13: 1.
33. Toyoda M, Puliyanda DP, Amet N, et al. Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients. Transplantation 2005; 80: 198.
34. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP,. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004; 4: 2109.
35. Ginevri F, De SantisR, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75: 1266.
36. Awadalla Y, Randhawa P, Ruppert K, Zeevi A, Duquesnoy RJ,. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant 2004; 4: 1691.
37. Hirsch HH, Steiger J,. Polyomavirus BK. Lancet Infect Dis. 2003; 3: 611.
38. Kotton CN, Fishman JA,. Viral infection in the renal transplant recipient. J Am Soc Nephrol 2005; 16: 1758.